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Role of inflammatory monocytes in adolescent
metabolic syndrome
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Abstract
Background
HYPOTHESES: 
1. Monocytes from Overwt-MetSyn subjects will 
have increased gene expression of TLRs and 
cytokines when compared to Overwt-Healthy 
and Lean subjects
2. TLR and cytokine expression will show a 
positive correlation with anthropometric and 
serum markers of metabolic disease
Materials/MethodsResults
•The recent epidemic of childhood obesity is placing 
countless children at risk for developing type 2 diabetes 
(T2DM), dyslipidemia, cardiovascular disease (CVD) and 
cancer
•Safe and effective pharmacological treatments are 
limited for obese children with metabolic disease
•Identification of the molecular and dietary triggers that 
link obesity with its associated co-morbidities is essential 
to recognize modifiable risk factors and target 
therapeutic interventions
•Currently, there is a paucity of data examining the 
expression and activity of TLR2 and TLR4 in obese 
adolescents
FIGURE 1. TLR2 and TLR4 signaling is stimulated by 
nutritional fatty acids and high glucose both of 
which are often elevated in the obese state.
TABLE. Clinical and biochemical characteristics of the study participants Participants
The subjects included in this pilot study were recruited from the
University of Massachusetts Boston and Worcester campuses. These
consenting individuals provided a fasting blood sample and a limited
history and physical examination were obtained. All subjects provided
written informed consent before taking part in the study and the
study was approved by the University of Massachusetts Institutional
Review Board. Subjects were classified as Overwt-MetSyn using a
modified definition proposed by the Adult Treatment Panel III as ≥ 3
of the following:(1) fasting triglycerides > 100 mg/dL; (2) HDL < 50
mg/dL (except in boys aged 15 to 19 years, in whom the cutpoint
was < 40 mg/dL); (3) fasting glucose ≥ 100 mg/dL; (4) waist
circumference >75th percentile for age and gender; and (5) systolic
blood pressure >90th percentile for gender, age, and height.
Exclusion criteria for study participation include the following: (a)
medical history of type 1 or type 2 diabetes, (b) any acute or chronic
inflammatory disease (i.e. rheumatoid arthritis, ulcerative colitis), (c)
cardiovascular or peripheral artery disease, (d) thyroid dysfunction,
(e) Cushing´s disease or hypercortisolism, (f) pregnancy (by self-
report), (g) medications that may affect outcome parameters
(metformin, lipid lowering medication, antihyperglycemic agents, oral
steroids), (h) genetic disease resulting in obesity, (i) presence of an
eating disorder.
Blood sample collection and monocyte isolation
Blood samples were be obtained via venipuncture after an 8 hour
overnight fast. Venous blood (15 mL total) was be collected in two
VacutainerTM Cell Preparation Tubes (Becton Dickinson, Rutherford,
NJ) with Na Citrate which are intended for the collection of whole
blood and the separation of mononuclear cells using a FICOLLTM
HypaqueTM solution. An additional 5 mL was collected in an EDTA
tube (VacutainerTM, Becton Dickinson) for whole blood hematology
analysis. Blood mononuclear cells were isolated from the
VacutainerTM Cell Preparation Tubes via centrifugation. Untouched
primary monocytes were further isolated from the mononuclear
fraction using a negative selection kit (Miltenyi Biotec, Germany).
Quantitative PCR and serum inflammatory markers
RNA was isolated from monocytes according to the QIAGEN MiniPrep
protocol. cDNA from total RNA was synthesized using the iScript
cDNA Synthesis Kit (Bio-Rad Laboratories). Quantitative real-time
PCR was used to quantify expression of TLR2, TLR4 and 2
inflammatory cytokines using SybrGreen assays according to
manufacturer’s instructions (Bio-Rad Laboratories). Expression of
specific mRNAs was quantified in duplicate samples on an iCycler IQ
Real-Time PCR detection system (Bio-Rad Laboratories) using the
∆∆CT method with normalization to cycle threshold measurements for
GAPDH.
Serum levels of inflammatory cytokines of interest (TNFα and IL6)
were measured in the initial fasting blood samples using ultra-
sensitive ELISA kits (R&D Systems).
Data Management
In our primary analyses, data from Overwt-MetSyn subjects and
Overwt-Healthy subjects was compared to determine the effect of
MetSyn on these outcome measures. In a secondary analysis, data
from Overwt-Healthy and Lean subjects was compared to determine
the effect of obesity on these outcome measures. Correlations were
assessed using Pearson’s coefficient. For all of the analyses, the
results were considered significant at P ≤ 0.05.
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Metabolic syndrome (MetSyn) is a cluster of risk factors
for cardiovascular disease and diabetes that affects 1 in
3 obese children. Inflammatory cytokines secreted
from macrophages are thought to be partly responsible
for the metabolic abnormalities associated with MetSyn.
This study aimed to determine whether peripheral blood
monocytes (macrophage precursors) from overweight
individuals with MetSyn (Overwt-MetSyn) demonstrate
enhanced activation of inflammatory signaling
pathways when compared to metabolically normal
overweight (Overwt-Healthy) or lean individuals. We
conducted a cross sectional pilot study involving 24
adolescents (six boys and eighteen girls) recruited from
the University of Massachusetts Boston and Worcester
campuses. Six subjects were classified as Overwt-
MetSyn using a modified definition proposed by the
International Diabetes Federation. The Overwt-MetSyn
group demonstrated an elevated expression of TLR2
and TLR4 in peripheral monocytes, and increased
circulating levels of TNFα and IL6. Expression of TLR2
and TLR4 showed a positive correlation with circulating
cytokines, and expression of TNFα correlated with waist
circumference and BMI. Metabolic syndrome in
adolescents is associated with increased activation of
the TLR signaling pathway in monocytes. The
knowledge gained from this study will advance our
understanding of the contribution of monocytes to the
pathophysiology of MetSyn.
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TLR2
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Mononuclear cells from obese adults 
have increased NFκB binding and 
increased expression of IL6 and Tnfα
Mice lacking TLR2 or TLR4 are 
protected from high fat diet 
induced insulin resistance
Mononuclear cells from adults with 
T1DM and T2DM have increased 
expression of TLR2, TLR4, CCL2 and 
increased secretion of IL6 and Tnfα
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Overwt MetSyn Overwt Healthy Lean
(n=6) (n=9) (n=9)
Female, No. (%) 6 (100) 6 (67) 6 (67)
Age (yr) 16.5 (15.4-17.2) 16.8 (15.9-19.8) 16.6 (15.6-18)
Ethnic group, No. (%)
  African American 4 (67) 6 (67) 7 (78)
  Caucasian 0 2 (22) 1 (11)
  Hispanic 2 (33) 1 (11) 1 (11)
BMI (kg/m2) 39 (30-52)* 32 (26-40)* 21 (18-25)^
BMI % 98 (96-99)* 94 (85-99)* 50 (36-84)^
Waist circumference 117 (98-142)** 95 (80-112)* 74 (61-83)^
Systolic BP (mm Hg) 122 (102-139) 117 (108-141) 114 (104-129)
Diastolic BP (mm Hg) 75 (61-84) 71 (53-85) 73 (63-81)
White blood cell counts (k/uL) 8 (5-12)* 6 (4-9) 6 (4-7)
Monocytes (%) 8 (4-12) 9 (6-14) 8 (5-11)
Cholesterol (mg/dL) 119 (72-162) 113 (83-155) 109 (73-145)
Triglyceride (mg/dL) 61 (23-125) 48 (24-97) 51 (34-90)
HDL (mg/dL) 40 (32-47) 41 (24-56) 42 (29-56)
LDL (mg/dL) 67 (27-90) 62 (49-100) 57 (32-81)
CRP (pg/mL) 3.5 (1-11) 3.1 (1-16) 1 (1-1)
Fasting glucose (mg/dL) 98 (82-119) 89 (66-109) 95 (84-110)
Fasting insulin (uIU/mL) 13 (2-31)* 6 (2-14) 3 (2-6)^
HOMA-IR 2.9 (0.8-7.1)* 1.3 (0.3-3.3) 0.7 (0.4-1.4)^
TNF ≤ pg/mL) 2.14 (0.75-4.66)** 0.86 (0-2.5) 0.95 (0.3-1.84)
IL6 (pg/mL) 2.75 (0.49-3.89)** 1.46 (0-2.74)* 0.61 (0-2.2)^
 
Data presented as mean (range)
* P < 0.05 compared with lean
** P < 0.05 compared with overweight healthy
^ P < 0.05 compared with all overweight (Overweight healthy and Metabolic syndrome)
nfα (pg/mL)
FIGURE 2. Monocytes from 
Overwt-MetSyn subjects 
display increased 
expression of inflammatory 
genes
FIGURE 4. Cytokine expression in 
monocytes correlates with BMI and 
central obesity
FIGURE 3. TLR expression in monocytes 
correlates with circulating cytokines
TLR4 expression
R2  p -value
Tnfα serum 0.2 0.02
IL6 serum 0.2 0.02
R2 = 0.46
p < 0.001
Tnfα expression
R2  p -value
BMI 0.2 0.05
R2 = 0.19
p < 0.03
Conclusions and Future Directions
1. Monocytes from Overwt-MetSyn subjects display 
increased gene expression of TLRs and cytokines
2. TLR expression shows a positive correlation with 
circulating cytokines; cytokine expression 
correlates with BMI and waist circumference
Ongoing research
1. Continue subjects recruitment
2. Assess TLR protein levels, surface markers
3. Measure secreted cytokines (Tnfa, IL6) from 
cultured monocytes at baseline and in 
response to TLR ligands and dietary lipids
Questions
1. Impact of dietary changes on monocyte inflammation?
2. Improvement in monocyte inflammation with weight loss and/or exercise?
3. Reversal of monocyte inflammation with pharmacotherapy or nutritional supplements?
Obese adolescent Obese adult
↑Tnfα, IL6 serum levels
↑TLR2, TLR4 gene expression in MetSyn
↑Tnfα, IL6 gene expression (trend) in MetSyn
